Clinical Trials List
Protocol NumberR115777-AML-301
Not yet recruiting
2006-01-01 - 2007-12-01
Phase III
Terminated1
-
Trial Applicant
Johnson & Johnson
-
Sponsor
-
Trial scale
-
Update
2026/02/01
Investigators and Locations
Principal Investigator
Co-Principal Investigator
The Actual Total Number of Participants Enrolled
0 Terminated
Condition/Disease
Objectives
Test Drug
Active Ingredient
Dosage Form
Dosage
Endpoints
Inclution Criteria
The Estimated Number of Participants
-
Taiwan
10 participants
-
Global
450 participants
